Inovio Pharmaceuticals
INO
#8585
Rank
A$0.39 B
Marketcap
A$2.12
Share price
-2.05%
Change (1 day)
-30.20%
Change (1 year)

Earnings for Inovio Pharmaceuticals (INO)

Earnings in 2026 (TTM): -A$0.13 Billion

According to Inovio Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -A$0.14 Billion, an increase over its 2024 earnings that were of -A$0.16 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Inovio Pharmaceuticals from 1999 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$0.13 Billion-8.33%
2025 -A$0.14 Billion-16.07%
2024 -A$0.16 Billion-20.03%
2023 -A$0.2 Billion-51.56%
2022 -A$0.41 Billion-8.26%
2021 -A$0.45 Billion95.4%
2020 -A$0.23 Billion36.62%
2019 -A$0.17 Billion20.19%
2018 -A$0.14 Billion10.94%
2017 -A$0.13 Billion9.59%
2016 -A$0.12 Billion118.9%
2015 -A$52.2 Million-10.67%
2014 -A$58.43 Million83.32%
2013 -A$31.88 Million
2011 -A$32.88 Million15.64%
2010 -A$28.44 Million37.7%
2009 -A$20.65 Million2.19%
2008 -A$20.21 Million-14.09%
2007 -A$23.52 Million19.12%
2006 -A$19.75 Million9.62%
2005 -A$18.02 Million5.77%
2004 -A$17.03 Million73.08%
2003 -A$9.84 Million12.75%
2002 -A$8.73 Million
2000 -A$13.21 Million53.93%
1999 -A$8.58 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$27.69 B-22,845.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$18.70 B-15,460.91%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$10.30 B-8,565.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-A$3.75 Billion 2,977.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$9.94 B-8,268.27%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$10.58 B-8,792.49%๐Ÿ‡ฌ๐Ÿ‡ง UK
Cleveland BioLabs
CBLI
-A$4.08 Million-96.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
-A$0.24 Billion 93.75%๐Ÿ‡บ๐Ÿ‡ธ USA